Anti-inflammatory effects of triptolide on IgA nephropathy in rats

References

• Wyatt RJ, Julian BA. IgA nephropathy. N Engl J Med 2013;368:2402–2414
   PubMed Web of Science ®Google Scholar
• Lin M, Du L, Brandtzaeg P, Pan-Hammarstrom Q. IgA subclass switch recombination in human mucosal and systemic immune compartments. Mucosal Immunol 2014;7:511–520
   PubMed Web of Science ®Google Scholar
• Roberts IS. Pathology of IgA nephropathy. Nat Rev Nephrol 2014;10:445–454
   PubMed Web of Science ®Google Scholar
• Myllymaki JM, Honkanen TT, Syrjanen JT, et al. Severity of tubulointerstitial inflammation and prognosis in immunoglobulin A nephropathy. Kidney Int 2007;71:343–348
   PubMed Web of Science ®Google Scholar
• Lundberg S, Lundahl J, Gunnarsson I, Jacobson SH. Atorvastatin-induced modulation of monocyte respiratory burst in vivo in patients with IgA nephropathy: a chronic inflammatory kidney disease. Clin Nephrol 2010;73:221–228
   PubMed Web of Science ®Google Scholar
• Kaartinen K, Syrjanen J, Porsti I, et al. Inflammatory markers and the progression of IgA glomerulonephritis. Nephrol Dial Transplant 2008;23:1285–1290
   PubMed Web of Science ®Google Scholar
• Latz E, Xiao TS, Stutz A. Activation and regulation of the inflammasomes. Nat Rev Immunol 2013;13:397–411
   PubMed Web of Science ®Google Scholar
• Turner CM, Arulkumaran N, Singer M, et al. Is the inflammasome a potential therapeutic target in renal disease? BMC Nephrol 2014;15:21–33
   PubMed Web of Science ®Google Scholar
• Yang SM, Ka SM, Hua KF, et al. Antroquinonol mitigates an accelerated and progressive IgA nephropathy model in mice by activating the Nrf2 pathway and inhibiting T cells and NLRP3 inflammasome. Free Radic Biol Med 2013;61:285–297
   PubMed Web of Science ®Google Scholar
• Murad S. Toll-like receptor 4 in inflammation and angiogenesis: a double-edged sword. Front Immunol 2014;5:313–317
   PubMed Web of Science ®Google Scholar
• Trotta T, Porro C, Calvello R, Panaro MA. Biological role of Toll-like receptor-4 in the brain. J Neuroimmunol 2014;268:1–12
   PubMed Web of Science ®Google Scholar
• Chen J, Hartono JR, John R, et al. Early interleukin 6 production by leukocytes during ischemic acute kidney injury is regulated by TLR4. Kidney Int 2011;80:504–515
   PubMed Web of Science ®Google Scholar
• Lim BJ, Lee D, Hong SW, Jeong HJ. Toll-like receptor 4 signaling is involved in IgA-stimulated mesangial cell activation. Yonsei Med J 2011;52:610–615
   PubMed Web of Science ®Google Scholar
• Tsutsui H, Imamura M, Fujimoto J, Nakanishi K. The TLR4/TRIF-mediated activation of NLRP3 inflammasome underlies endotoxin-induced liver injury in mice. Gastroenterol Res Pract 2010;2010:641865. doi: 10.1155/2010/641865
   PubMed Web of Science ®Google Scholar
• Qi Y, Zhao M, Bai Y, et al. Retinal ischemia/reperfusion injury is mediated by Toll-like receptor 4 activation of NLRP3 inflammasomes. Invest Ophthalmol Vis Sci 2014;55:5466–5475
   PubMed Web of Science ®Google Scholar
• Han R, Rostami-Yazdi M, Gerdes S, Mrowietz U. Triptolide in the treatment of psoriasis and other immune-mediated inflammatory diseases. Br J Clin Pharmacol 2012;74:424–436
   PubMed Web of Science ®Google Scholar
• Liang Q, Zhang J, Tang W, et al. Triptolide attenuates acute small-for-size liver graft injury in rats by inhibition of Toll-like receptor 4. Transplant Proc 2014;46:3303–3308
   PubMed Web of Science ®Google Scholar
• Wei D, Huang Z. Anti-inflammatory effects of triptolide in LPS-induced acute lung injury in mice. Inflammation 2014;37:1307–1316
   PubMed Web of Science ®Google Scholar
• Zhou ZL, Yang YX, Ding J, et al. Triptolide: structural modifications, structure-activity relationships, bioactivities, clinical development and mechanisms. Nat Prod Rep 2012;29:457–475
   PubMed Web of Science ®Google Scholar
• Leuenroth SJ, Okuhara D, Shotwell JD, et al. Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease. Proc Natl Acad Sci USA 2007;104:4389–4394
   PubMed Web of Science ®Google Scholar
• Chen ZH, Qin WS, Zeng CH, et al. Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b-9-induced podocyte injury in vitro. Kidney Int 2010;77:974–988
   PubMed Web of Science ®Google Scholar
• Gao Q, Shen W, Qin W, et al. Treatment of db/db diabetic mice with triptolide: a novel therapy for diabetic nephropathy. Nephrol Dial Transplant 2010;25:3539–3547
   PubMed Web of Science ®Google Scholar
• Katzir Z, Leibovitch E, Vaknin H, et al. Effect of atorvastatin on IgA nephropathy in the rat. Clin Nephrol 2013;79:214–220
   PubMed Web of Science ®Google Scholar
• He L, Peng X, Zhu J, et al. Protective effects of curcumin on acute gentamicin-induced nephrotoxicity in rats. Can J Physiol Pharmacol 2015;93:275–282
   PubMed Web of Science ®Google Scholar
• Li XJ, Jiang ZZ, Zhang LY. Triptolide: progress on research in pharmacodynamics and toxicology. J Ethnopharmacol 2014;155:67–79
   PubMed Web of Science ®Google Scholar
• Pillai U, Balabhadraputani K, Bhat Z. Immunoglobulin A nephropathy: a review of current literature on emerging pathophysiology. Am J Med Sci 2014;347:249–253
   PubMed Web of Science ®Google Scholar
• Kim MJ, McDaid JP, McAdoo SP, et al. Spleen tyrosine kinase is important in the production of proinflammatory cytokines and cell proliferation in human mesangial cells following stimulation with IgA1 isolated from IgA nephropathy patients. J Immunol 2012;189:3751–3758
   PubMed Web of Science ®Google Scholar
• Pei G, Zeng R, Han M, et al. Renal interstitial infiltration and tertiary lymphoid organ neogenesis in IgA nephropathy. Clin J Am Soc Nephrol 2014;9:255–264
   PubMed Web of Science ®Google Scholar
• Liu H, Peng Y, Liu F, et al. Expression of IgA class switching gene in tonsillar mononuclear cells in patients with IgA nephropathy. Inflamm Res 2011;60:869–878
   PubMed Web of Science ®Google Scholar
• Graziose R, Lila MA, Raskin I. Merging traditional Chinese medicine with modern drug discovery technologies to find novel drugs and functional foods. Curr Drug Discov Technol 2010;7:2–12
   PubMedGoogle Scholar
• Lu Y, Wang WJ, Leng JH, et al. Inhibitory effect of triptolide on interleukin-18 and its receptor in rheumatoid arthritis synovial fibroblasts. Inflamm Res 2008;57:260–265
   PubMed Web of Science ®Google Scholar
• Gao J, Zhan Y, Chen J, et al. Triptolide ameliorates lipopolysaccharide-induced acute lung injury in rats. Eur J Med Res 2013;18:58–64
   PubMed Web of Science ®Google Scholar
• Yu C, Shan T, Feng A, et al. Triptolide ameliorates Crohn’s colitis is associated with inhibition of TLRs/NF-kappaB signaling pathway. Fitoterapia 2011;82:709–715
   PubMed Web of Science ®Google Scholar
• Coppo R, Camilla R, Amore A, et al. Toll-like receptor 4 expression is increased in circulating mononuclear cells of patients with immunoglobulin A nephropathy. Clin Exp Immunol 2010;159:73–81
   PubMed Web of Science ®Google Scholar
• Hua KF, Yang SM, Kao TY, et al. Osthole mitigates progressive IgA nephropathy by inhibiting reactive oxygen species generation and NF-kappaB/NLRP3 pathway. PLoS One 2013;8:e77794. doi: 10.1371/journal.pone.0077794
   PubMed Web of Science ®Google Scholar
• Bi J, Song S, Fang L, et al. Porcine reproductive and respiratory syndrome virus induces IL-1beta production depending on TLR4/MyD88 pathway and NLRP3 inflammasome in primary porcine alveolar macrophages. Mediators Inflamm 2014;2014:403515. doi: 10.1155/2014/403515
   PubMed Web of Science ®Google Scholar